Sri Lanka’s Ceylinco Radiation Treatment Centre invests in upgrading facility
The Ceylinco Radiation Treatment Centre in Sri Lanka, which is the only private hospital in the country to offer Brachytherapy (internal radiation) for the treatment of cancer, has reportedly announced upgrades to its treatment planning and delivery systems to further improve accuracy and efficiency.
An investment of Rs 15 million is to upgrade Consultant Oncologists and Medical Physicists involved in treatment planning enhanced capabilities to plan and deliver the required precision treatments, the Centre has stated.
Brachytherapy is a treatment that involves placing radioactive material in the body of the cancer patient. It is used for treating cervical and endometrial cancer as well as oesophageal, head and neck, vaginal, rectal and lung cancers, according to reports.
Elaborating on the upgrade, the Centre has been quoted as saying in the local media that the installation of new Treatment Planning System (TPS) hardware using the latest Oncentra Brachy 4.6 version upgrade and Treatment Delivery System upgrade with the newest Treatment Console System (TCS)hardware running on the MHDR V3 TCS 3.1.6 upgrade, was undertaken by DIMO, the local agent for Elekta Medical Systems of the Netherlands.
Components such as the GYN Transfer Tube sets, X-Ray Catheter sets, and the Fletcher-Williamson applicator sets have also been replaced with the upgrade.
With the upgrade, cancer patients can experience more precise treatments offered by the new software which has 3D contouring and margin tools for anatomy definitions and image registration, fast catheter reconstruction algorithms for implant reconstructions, dose point optimisation and geometric optimisation. Plan analysis tools such as synchronized plan evaluation for comparison are also an advantage.
Sri Lanka’s health sector is constantly developing/upgrading to be on par with the latest trends in the global health industry. The government of Sri Lanka is also committed to increasing the country’s capacity to manufacture pharmaceuticals to meet the local demand as well as to explore export opportunities. A dedicated pharma zone is to be set up especially for this purpose granting incentives. Foreign businesses/investors could therefore explore business/investment opportunities in Sri Lanka’s health industry.
|Article Code :||VBS/AT/20210113/Z_4|